Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001213900-26-009570·Nano Dimension Ltd.
Schedule 13D ownership disclosure
NANO DIMENSION LTD
Ordinary Shares, par value NIS 5.00 per share · CUSIP: 63008G203
Event date: 2026-01-29
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Oramed Pharmaceuticals Inc.Reported CIK 0001176309
Shares: 10,413,730.00 · Class: 5.0%
- Nadav KidronReported CIK 0001351779
Shares: 10,549,430.00 · Class: 5.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-26-009570
- Form type
- SCHEDULE 13D
- Filer
- Nano Dimension Ltd.
- CIK
- CIK 1643303
- Filed
- Jan 29, 2026
- Reporting period
- Jan 29, 2026
- Description
- Schedule 13D beneficial ownership